share_log

盘中速览 | 港股三大指数表现强势,科指涨超3%;汽车股领涨,蔚来涨超5%

Intraday Overview | The three major indices of Hong Kong stocks showed strong performance, with the technical index rising more than 3%; auto stocks led the way, and NIO rose more than 5%

Futu News ·  Jun 3 10:51

Futu News reported on June 3 that the three major indices of Hong Kong stocks opened high and rose strongly. As of press release, the Hang Seng Index was up 2.6%, the Tech Index was up 3.16%, and the National Index was up 2.94%.

On the sector side, auto stocks led the way, with GAC Group rising more than 6%, Ideal Auto and NIO rising nearly 6%, BYD shares rising more than 5%, and Geely Automobile and Great Wall Motors rising more than 4%.

TechNet stocks rebounded. Bilibili rose nearly 5%, Meituan rose more than 4%, Tencent and Ctrip rose nearly 4%, NetEase and Xiaomi rose more than 3%, and Alibaba rose nearly 3%.

Apple's concept stocks improved. BYD Electronics rose nearly 7%, Shunyu Optical Technology rose more than 4%, and Qiu Titanium Technology rose more than 3%.

Port and shipping stocks generally rose, with COSCO Marine Control up nearly 7%, Orient Overseas International up more than 5%, COSCO Marine up nearly 5%, and COSCO Marine Energy up more than 3%.

Catering stocks picked up, with Haidilao up nearly 5%, Yum China up more than 4%, and Jiumaojiu, Helen's, and Dajayle Group rising more than 2%.

Domestic housing stocks rose; Greentown China rose more than 5%; Midea Real Estate and China Overseas Development rose more than 4%; Longhu Group and Yuexiu Real Estate rose more than 3%.

In terms of individual stocks,$UBOT HOLDING (08529.HK)$It was first listed, opened 32% higher in early trading, then fluctuated and declined, and is now up 6%.

$HUA HONG SEMI (01347.HK)$Chip stocks rose by more than 7%, and the revenue of the global foundry industry increased 12% year on year in Q1.

$CSTONE PHARMA-B (02616.HK)$With an increase of more than 11%, the European Commission on Medicines for Human Use recommended approval of sugarizumab for first-line treatment of non-small cell lung cancer.

$GENSCRIPT BIO (01548.HK)$It fell 20% and was investigated by a US House Committee.

edit/lambor

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment